Speaker: 

Dr. Kasmintan Schrader, MBBS, FRCPC, PhD, DABMG - Co-Medical Director, BC Cancer Hereditary Cancer Program
Assistant Professor, Department of Medical Genetics, The University of British Columbia

Session Overview:

In this informative session, Dr. Intan Schrader will provide a look at the latest research and future developments in BRCA-related cancer care. As a leader in hereditary cancer research, Dr. Schrader will focus on what current studies mean for BRCA carriers, particularly in the areas of early detection and personalized treatment.

Dr. Schrader will discuss how new advancements in genetic testing, like long-read sequencing, are improving our ability to detect BRCA mutations and differentiate between hereditary and non-hereditary cancers. These advancements help in identifying cancer risks earlier and more accurately, leading to better prevention strategies and treatment options tailored to individuals.

The session will also highlight ongoing research efforts aimed at understanding how BRCA mutations affect cancer development and what this means for the future of cancer care. Dr. Schrader will explain how these studies are helping doctors develop new ways to detect cancer early and create more effective treatments specifically for people with BRCA mutations.

Key Topics:

• Advances in Genetic Testing: How new technologies are helping to better identify and manage BRCA-related cancer risks.

• Current Research in BRCA: What studies are telling us about the best ways to prevent, detect, and treat BRCA-related cancers.

• The Future of BRCA Care: Emerging treatments and early detection methods that are on the horizon.

• Q&A: An opportunity to ask Dr. Schrader questions and learn more about how this research impacts you.

You can find the recording here.